Adirondack Research & Management’s Axcelis ACLS Stock Holding History

Adirondack Research & Management’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,600	Closed	-$161K	–	114
2017 Q4	$161K	Sell	5,600 -48,293	-90%	-$1.52M	0.06%	107
2017 Q3	$1.47M	Sell	53,893 -53,602	-50%	-$1.19M	0.58%	55
2017 Q2	$2.25M	Sell	107,495 -241,267	-69%	-$5.1M	0.88%	48
2017 Q1	$6.56M	Sell	348,762 -70,476	-17%	-$1.11M	2.36%	7
2016 Q4	$6.1M	Hold	419,238	–	–	2.07%	12
2016 Q3	$5.57M	Buy	419,238 +3,709	+0.9%	+$43K	2.01%	15
2016 Q2	$4.47M	Buy	415,529 +19,941	+5%	+$214K	1.68%	22
2016 Q1	$4.43M	Buy	395,588 +25,425	+7%	+$260K	1.61%	23
2015 Q4	$3.83M	Buy	370,163 +36,172	+11%	+$384K	1.39%	31
2015 Q3	$3.57M	Buy	333,991 +132,199	+66%	+$1.61M	1.37%	34
2015 Q2	$2.39M	Buy	+201,792	New	+$2.34M	0.88%	53

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adirondack Research & Management's ACLS Position: Q1 2018 in Review

Adirondack Research & Management sold out of Axcelis (ACLS) in Q1 2018, closing a stake of 5,600 shares — an estimated $161K sold.

Adirondack Research & Management first reported a position in ACLS in Q2 2015 and held it in 11 quarters. The position peaked at $6.56M in Q1 2017. 165 funds tracked by Wall St. Rank hold ACLS as of Q1 2018.

Adirondack Research & Management reported no remaining Axcelis position as of Q1 2018 after selling out during the quarter.
Adirondack Research & Management sold 5,600 Axcelis shares in Q1 2018, an estimated $161K.
Adirondack Research & Management first reported a position in Axcelis in Q2 2015 and held it in 11 quarters.
Adirondack Research & Management's Axcelis position peaked at $6.56M in Q1 2017.
165 funds tracked by Wall St. Rank held Axcelis as of Q1 2018.

Based on Adirondack Research & Management's 13F filing for Q1 2018, filed 14 May 2018.